HEMOSENSE INC 4
4 · HEMOSENSE INC · Filed Nov 7, 2007
Insider Transaction Report
Form 4
SANGSTER GORDON
Chief Financial Officer
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-11-06−27,790→ 0 totalExercise: $8.60Exp: 2017-05-24→ Common Stock (27,790 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−2,210→ 0 totalExercise: $8.60Exp: 2017-05-24→ Common Stock (2,210 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−60,000→ 0 totalExercise: $3.00Exp: 2016-09-18→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]This option was assumed by Inverness Medical Innovations, Inc. ("Inverness") in the merger and replaced with an option to purchase shares of Inverness common stock. The number of shares of Inverness common stock subject to the assumed option is calculated by multiplying the number of shares of HemoSense common stock subject to the options held by 0.274192, rounded down on a per-option basis to the next whole share. The exercise price of the assumed option is equal to the exercise price of the HemoSense option divided by 0.274192, rounded up to the next cent.